NuVasive, Alphatec, Medtronic & more: 17 device company notes

Written by Anuja Vaidya | October 13, 2017 | Print  |

Here are 17 key notes on orthopedic and spine device companies from the past week.

NuVasive filed a lawsuit against former President, COO and Vice Chairman Patrick Miles for breach of fiduciary duties and contract violation after the executive resigned from the company to become Alphatec's executive chairman.

 

Alphatec Holdings responded Oct. 11 to a lawsuit NuVasive filed Oct. 10 against former NuVasive board member and current Alphatec Executive Chairman Patrick Miles, calling the allegations baseless and fictional.

 

Medtronic broke ground on a new innovation center in China — the Chengdu Innovation Center at the Singapore-Sichuan Hi-Tech Innovation Park in Sinchuan Province.

 

Mazor Robotics received 22 system purchase orders in the second quarter, including 19 for the Mazor X system; Medtronic made 11 of those purchases.

 

K2M expects to report a 6 percent increase in third quarter revenue, totaling $62.7 million, which is lower than expected due to decreased volume in areas affected by Hurricane Harvey and Hurricane Irma.

 

DePuy Synthes launched Maxframe Multi-Axial Correction System, an external circular fixation device used to correct bone or tissue deformities in arms, legs or ankles.

 

Stryker plans to launch its 3-D Tritanium C Anterior Cervical Cage next quarter.

 

The Medicrea Group will launch its UNiD HUB software in Europe in October.

 

Implanet reported third quarter 2017 revenue grew 20 percent year-over-year.

 

Joimax reported 60 percent growth year-over-year in the third quarter of 2017.

 

The first spine surgeries using Globus Medical's ExcelsiusGPS were performed by Nick Theodore, MD, Ali Bydon, MD, and Kade Huntsman, MD, at two different hospitals.

 

Zeshan Hyder, DO, and Frank K. Kuwamura, III, MD, performed the first spine cases using Nvision Biomedical Technologies devices featuring Structural Encoding technology.

 

AxioMed closed its first round of funding, with its anticipated second round already securing $10 million in pledges.

 

DSM Biomedical is teaming up with Cerapedics to create the next-generation peptide enhanced bone graft.

 

Synaptive Medical launched its Modus V, an optics platform featuring a surgical robotic arm.

 

Mainstay Medical appointed Jason Hannon to its board of directors, effective immediately.

 

OrthAlign received Australian Therapeutic Goods Administration approval for its Direct Anterior Approach HipAlign and partial knee arthroplasty UniAlign.

 

More articles on devices:
OrthAlign earns approval for DAA HipAlign, UniAlign technology in Australia: 5 things to know
Global spinal cord stimulation device market to grow at 5.7% CAGR — 3 observations
joimax sees record revenue in Q3 2017 — 4 highlights

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months